CJC-1295 no DAC + Ipamorelin
CJC-1295 no DAC + Ipamorelin is a co-lyophilized research mixture of modified GRF(1–29) without a drug-affinity complex plus the ghrelin-receptor peptide ipamorelin, listed at https://onesourcepeptides.com/product/cjc-1295-no-dac-5mg-plus-ipamorelin-5mg.
Listings usually mark the pair as equal parts. Modified GRF(1–29) without DAC is discussed as a short analogue at the GHRH receptor. Ipamorelin is the pentapeptide Aib-His-D-2Nal-D-Phe-Lys-NH2, described by Raun et al. (European Journal of Endocrinology, 1998, 139:552–561) as a selective agonist at the ghrelin receptor, with growth-hormone release in animal pharmacology and little movement of ACTH or cortisol relative to older secretagogues in that study. Both pathways are used in models of growth-hormone signalling, which is why catalogs put them in one vial.
A controlled study of this exact co-lyophilized ratio was not identified for this note. Each parent peptide has its own papers. The blend is a research formulation, not an approved combination, and a catalog name does not create a literature the pair does not have.
This page does not discuss physique, aging, or performance. It names the signalling classes on the listing.